To curb misuse, India's Drug Controller General has intensified regulatory surveillance, inspecting businesses and warning of strict action against unauthorised sale and misleading promotion Watch the full video to understand the nuances of GLP-1 drugs in India Ministry of Health and Family Welfare, Government of India | Press Information Bureau - PIB, Government of India
These customers are eating with purpose now, so every bite needs to deliver nutritional value
Probiotics can help stabilize th
As GLP-1 RAs become more prevalent in treating diabetes and patients with cardiovascular disease (CVD) or risk factors for CVD, clinicians will ultimately manage the practical aspects of patient selection, dosing, special considerations, and side effects of these medications
NAD+ precursors are generally well-tolerated, but any addition to an active prescription protocol warrants a conversation with the prescribing provider
A SGLT2i + DPP4i FDC is a suitable option for Indian T2D patients, for the following reasons: Safer, rapid, and sustained glycemic control Improves both insulin resistance and beta cell function Helps reduce body weight and blood pressure (extraglycemic benefits) Reduces pill burden (adherence and compliance improves) Overall cost effective The following decision-making algorithms (Fig
